Patrick G. Kehoe

27.7k total citations · 1 hit paper
187 papers, 8.4k citations indexed

About

Patrick G. Kehoe is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Patrick G. Kehoe has authored 187 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Physiology, 48 papers in Cardiology and Cardiovascular Medicine and 43 papers in Molecular Biology. Recurrent topics in Patrick G. Kehoe's work include Alzheimer's disease research and treatments (84 papers), Dementia and Cognitive Impairment Research (36 papers) and Renin-Angiotensin System Studies (29 papers). Patrick G. Kehoe is often cited by papers focused on Alzheimer's disease research and treatments (84 papers), Dementia and Cognitive Impairment Research (36 papers) and Renin-Angiotensin System Studies (29 papers). Patrick G. Kehoe collaborates with scholars based in United Kingdom, United States and Italy. Patrick G. Kehoe's co-authors include Seth Love, J. Scott Miners, Gordon Wilcock, Shabnam Baig, Jennifer C Palmer, Laura E. Palmer, Emma L. Ashby, Zoë Van Helmond, Katy Chalmers and Richard M. Martin and has published in prestigious journals such as Chemical Reviews, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Patrick G. Kehoe

185 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint

2023 75 citations Patrick G. Kehoe et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick G. Kehoe United Kingdom	51	3.9k	2.5k	1.4k	1.3k	1.1k	187	8.4k
Teng Jiang China	58	3.4k 0.9×	3.4k 1.4×	2.6k 1.9×	706 0.5×	977 0.9×	215	10.8k
Christiane Reitz United States	40	3.7k 1.0×	1.9k 0.8×	1.3k 0.9×	738 0.6×	673 0.6×	113	8.1k
Ming‐Xin Tang United States	43	4.1k 1.0×	1.7k 0.7×	1.1k 0.8×	918 0.7×	691 0.6×	75	10.0k
Yan‐Jiang Wang China	50	4.3k 1.1×	2.7k 1.1×	1.8k 1.3×	261 0.2×	1.2k 1.0×	307	9.8k
Magnus Sjögren Sweden	48	3.8k 1.0×	2.1k 0.8×	1.7k 1.2×	391 0.3×	907 0.8×	142	8.6k
Meng‐Shan Tan China	49	3.6k 0.9×	2.7k 1.1×	2.5k 1.8×	281 0.2×	775 0.7×	127	9.3k
Bruce W. Patterson United States	66	7.1k 1.8×	3.7k 1.5×	571 0.4×	1.8k 1.4×	700 0.6×	236	16.2k
Suzanne M. de la Monte United States	70	7.0k 1.8×	6.3k 2.6×	2.4k 1.7×	471 0.4×	2.5k 2.2×	288	18.5k
Elizabeth H. Corder United States	28	6.7k 1.7×	3.6k 1.5×	1.5k 1.1×	341 0.3×	1.4k 1.2×	59	11.3k
Masafumi Ihara Japan	57	2.4k 0.6×	2.1k 0.9×	4.7k 3.4×	713 0.6×	1.1k 0.9×	357	11.2k

Countries citing papers authored by Patrick G. Kehoe

Since Specialization

Citations

This map shows the geographic impact of Patrick G. Kehoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick G. Kehoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick G. Kehoe more than expected).

Fields of papers citing papers by Patrick G. Kehoe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick G. Kehoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick G. Kehoe. The network helps show where Patrick G. Kehoe may publish in the future.

Co-authorship network of co-authors of Patrick G. Kehoe

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick G. Kehoe. A scholar is included among the top collaborators of Patrick G. Kehoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick G. Kehoe. Patrick G. Kehoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Petr, Jan, et al.. (2025). Advantages and challenges of using arterial spin labelling MRI to monitor cerebral blood flow in multi-centre clinical trials of neurodegenerative disease: Experience from the RADAR study. PubMed. 8. 100376–100376.

Smallwood, Miranda J., Andrew R. Pitt, Corinne M. Spickett, et al.. (2025). Hemoglobin in the brain frontal lobe tissue of patients with Alzheimer’s disease is susceptible to reactive nitrogen species-mediated oxidative damage. Redox Biology. 82. 103612–103612. 3 indexed citations

Perks, Claire M., et al.. (2025). Curious Dichotomies of Apolipoprotein E Function in Alzheimer’s Disease and Cancer—One Explanatory Mechanism of Inverse Disease Associations?. Genes. 16(3). 331–331. 2 indexed citations

Shao, Xiaojian, Sangeetha Vishweswaraiah, Miroslava Čuperlović‐Culf, et al.. (2022). Dementia with Lewy bodies post-mortem brains reveal differentially methylated CpG sites with biomarker potential. Communications Biology. 5(1). 1279–1279. 2 indexed citations

Akyol, Sümeyya, Zafer Ugur, Ali Yılmaz, et al.. (2021). Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism. Cells. 10(10). 2591–2591. 82 indexed citations

Walker, Venexia, Neil M Davies, Richard M. Martin, & Patrick G. Kehoe. (2020). Comparison of Antihypertensive Drug Classes for Dementia Prevention. Epidemiology. 31(6). 852–859. 16 indexed citations

Walker, Venexia, Patrick G. Kehoe, Richard M. Martin, & Neil M Davies. (2019). Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study. International Journal of Epidemiology. 49(4). 1132–1140. 57 indexed citations

Kehoe, Patrick G., Peter S Blair, Beth Howden, et al.. (2017). The Rationale and Design of the Reducing Pathology in Alzheimer’s Disease through Angiotensin TaRgeting (RADAR) Trial. Journal of Alzheimer s Disease. 61(2). 803–814. 26 indexed citations

Walker, Venexia, Neil M Davies, Tim Jones, Patrick G. Kehoe, & Richard M. Martin. (2016). Can commonly prescribed drugs be repurposed for the prevention or treatment of Alzheimer's and other neurodegenerative diseases? Protocol for an observational cohort study in the UK Clinical Practice Research Datalink. BMJ Open. 6(12). e012044–e012044. 12 indexed citations

10.

Kehoe, Patrick G., et al.. (2016). Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology. Alzheimer s Research & Therapy. 8(1). 50–50. 155 indexed citations

11.

Tayler, Hannah, et al.. (2014). Investigating the relationship between cerebral A beta(40) and systemic hypertension. Neuropathology and Applied Neurobiology. 40. 41–41. 1 indexed citations

12.

Corry, David B., Christopher Lee, Andrew J. Wilson, et al.. (2013). The Branched-Chain Aminotransferase Proteins: Novel Redox Chaperones for Protein Disulfide Isomerase–Implications in Alzheimer's Disease. Antioxidants and Redox Signaling. 20(16). 2497–2513. 25 indexed citations

13.

Kehoe, Patrick G., et al.. (2011). LRP-1-mediated uptake of A beta by cerebrovascular smooth muscle cells: relationship to cytotoxicity. Neuropathology and Applied Neurobiology. 37. 10–10. 1 indexed citations

14.

Frisardi, Vincenza, Vincenzo Solfrizzi, Cristiano Capurso, et al.. (2010). Aluminum in the diet and Alzheimer's disease. Journal of Alzheimer s Disease. 20(1). 17–30. 39 indexed citations

15.

Panza, Francesco, et al.. (2009). International Handbook of Behavior, Diet and Nutrition. Springer US. 14 indexed citations

16.

Helmond, Zoë Van, J. Scott Miners, Patrick G. Kehoe, & Seth Love. (2009). Oligomeric Aβ in Alzheimer's Disease: Relationship to Plaque and Tangle Pathology, APOE Genotype and Cerebral Amyloid Angiopathy. Brain Pathology. 20(2). 468–480. 36 indexed citations

17.

Cortina‐Borja, Mario, et al.. (2005). Large-scale meta-analysis establishes the association of the ACE indel polymorphism with Alzheimer’s disease. UCL Discovery (University College London). 1 indexed citations

18.

Chalmers, Katy, et al.. (2004). APOE promoter, ACE1 and CYP46 polymorphisms and β-amyloid in Alzheimer's disease. Neuroreport. 15(1). 95–98. 17 indexed citations

19.

Deb, Shoumitro, et al.. (1998). No significant association between a PS-1 intronic polymorphism and dementia in Down's syndrome. Bristol Research (University of Bristol). 3 indexed citations

20.

Kehoe, Patrick G., Julie Williams, Simon Lovestone, Gordon Wilcock, & Michael John Owen. (1996). Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group. Journal of Psychopharmacology. 347(9009). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact